FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

CGMP Violations at Brigham and Womens Hospital

FDA warns Boston, MA-based Brigham and Womens Hospital about CGMP violations in its production of positron emission tomography drugs.

Human Drugs

FDA Accelerating Rare Disease Cures Program

CDER launches its new Accelerate Rare disease Cures program to speed and increase the development of effective and safe treatment options for patients...

Human Drugs

Mesa Biotech Covid-19 Test Recalled

Mesa Biotech recalls its Accula SARS-CoV-2 Test because certain lots of the device have an increased risk of giving false positive results due to cont...

Human Drugs

Inhousepharmacy Selling Illegal Unapproved Drugs: FDA

FDA warns inhousepharmacy.vu that it is illegally marketing domperidone drug products in the U.S.

Medical Devices

Dont Use Skippack Covid Rapid Test: FDA

FDA says the Skippack Medical Laboratory recall of rapid Covid-19 tests that were not cleared, approved, or authorized is Class 1 and people should no...

Biologics

Committee Documents Emergent Manufacturing Failures

A House committee staff report blasts Emergent Biosolutions for hiding its Covid-19 vaccine manufacturing problems from FDA and HHS.

Human Drugs

Lillys Olumiant Approved for Covid-19

FDA approves a new indication for Eli Lillys Olumiant (baricitinib) for treating Covid-19 in hospitalized adults requiring supplemental oxygen, non-in...

Federal Register

FDA Revokes EUAs on 2 Covid Tests

FDA revokes a Bio-Rad Laboratories Emergency Use Authorization (EUA) and a Bio- Applied DNA Sciences EUA for their no-longer-distributed Covid-19 test...

Human Drugs

Guidance on Considerations for Drug Quality Assessments

FDA posts a draft guidance entitled Benefit-Risk Considerations for Product Quality Assessments, which describes the agencys benefit-risk principles u...

Medical Devices

Draft Guide on Cybersecurity for Legacy Devices

The International Medical Device Regulators Forum (IMDRF), of which FDA is a member, seeks comments on a proposed guidance entitled Principles and Pra...